Lawrence S. Blaszkowsky

Author

Also Known As

Jennifer Wo, Joseph A. Blansfield, L S Blaszkowsky, L. Blaszkowsky, L. S. Blaszkowsky, L.S. Blaszkowsky, Lawrence Blaszkowsky, Lawrence S Blaszkowsky, Lawrence S. Blaszkowsky, Lawrence S. Blazkowsky

364

Publications

16.2K

Citations

H-Index

Concepts

All Affiliations

Massachusetts General Hospital Harvard University Dana-Farber Cancer Institute Brigham and Women's Hospital Dana-Farber Brigham Cancer Center

About

Lawrence S. Blaszkowsky is an author at Massachusetts General Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	80	7.5K
2	Health Sciences	22	31	2.2K
3	Engineering	2	2	85
4	Public Health	2	2	49
5	Cell Biology	1	1	54

Lawrence S. Blaszkowsky

134

Publications

15.3K

Citations

H-Index

Page 1

	Year	Citations
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer Christopher G. Willett, Yves Boucher, Emmanuelle di Tomaso, Nature Medicine AngiogenesisMedicineHuman Rectal CancerImmunologyPathology	2004	1.9K
Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer Cristina R. Ferrone, Giovanni Marchegiani, Theodore S. Hong, Annals of Surgery	2014	823
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology Manisha H. Shah, Whitney Goldner, Al B. Benson, Journal of the National Comprehensive Cancer Network Surgical OncologyAdrenal TumorsPathologyGliomaTumor Biology	2021	542
Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma Janet E. Murphy, Jennifer Y. Wo, David P. Ryan, JAMA Oncology	2018	531
Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers Aparna R. Parikh, Ignaty Leshchiner, Liudmila Elagina, Nature Medicine Gastrointestinal OncologyTumor HeterogeneityMedicineCancer DetectionGastrointestinal Cancers	2019	513
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer Janet E. Murphy, Jennifer Y. Wo, David P. Ryan, JAMA Oncology	2019	484
Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study Andrew X. Zhu, Dushyant V. Sahani, Dan G. Duda, Journal of Clinical Oncology	2009	473
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Theodore S. Hong, Jennifer Y. Wo, Beow Y. Yeap, Journal of Clinical Oncology	2015	461
Pancreatic Ductal Adenocarcinoma Ioannis T. Konstantinidis, Andrew L. Warshaw, Jill N. Allen, Annals of Surgery	2012	418
Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer Mariangela Russo, Giulia Siravegna, Lawrence S. Blaszkowsky, Cancer Discovery	2015	400

Page 1